US MedTech leader Karen Holzberger appointed CEO
Open PDF
| Stock | Painchek Ltd (PCK.ASX) |
|---|---|
| Release Time | 20 Jul 2026, 8:58 a.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
PainChek Appoints Karen Holzberger as New CEO
Key Points
- Karen Holzberger appointed as CEO effective from 17 August 2026.
- Holzberger has 26 years of healthcare leadership in US medtech companies.
- Andy Hoggan will return to COO role after interim CEO stint.
Full Summary
PainChek Ltd (ASX: PCK), a developer of an AI-powered pain assessment application, announces the appointment of Karen Holzberger as CEO, effective from 17 August 2026. Holzberger, a seasoned US MedTech leader, brings extensive experience in growing early-stage and large international medtech companies. She will focus on expanding PainChek's presence in the US and other markets. Andy Hoggan, currently Interim CEO, will resume his role as Chief Operating Officer.
Sign in to get more information about the company, including guidance changes and other insights.
Sign In